Ongoing clinical trials and approved products targeting Choline (membrane metabolism), in radioligand therapy and PET/SPECT imaging. Data as of 26 October 2026.
| Choline ([11C] Mayo, [18F] IASOcholine…)[11C]choline, [18F]fluorocholine | Multiples | marketed | US EU FR |
| Trial | Phase | Status | Sponsor | Countries |
|---|---|---|---|---|
| Labeled choline ([18F]/[11C])2025-520861-29-00 · Prostate – other | Phase 3 | Not yet recruiting | A.C.O.M. Advanced Center Oncology Macerata S.r.l. | 1 |
| Labeled choline ([18F]/[11C])NCT04150458 · Other | Phase 3 | By invitation | Sir Mortimer B. Davis - Jewish General Hospital | 1 |
| F-choline · Labeled choline ([18F]/[11C])NCT04999215 · Other | Phase 3 | Recruiting | Centre hospitalier de l'Université de Montréal (CHUM) | 1 |
| Labeled choline ([18F]/[11C])NCT07444723 · Hyperparathyroidism | Phase 3 | Recruiting | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 1 |
| ExTRACT-HCC · Labeled choline ([18F]/[11C])NCT04965454 · Liver (HCC) | Phase 2 | Recruiting | Queen's Medical Center | 1 |
| Labeled choline ([18F]/[11C])NCT07138820 · Hyperparathyroidism | No phase | Recruiting | Region Skane | 1 |
| Labeled choline ([18F]/[11C])NCT05359939 · Liver (HCC) | No phase | Recruiting | University of Aarhus | 1 |
| OPERANDI-HCC · Labeled choline ([18F]/[11C])NCT06334965 · Liver (HCC) | No phase | Recruiting | Assistance Publique - Hôpitaux de Paris | 1 |
Choline (membrane metabolism). Theranostic Atlas, LaRadiopharmacie.fr. Data as of 26 October 2026. https://theranosticatlas.com/target/choline-membrane-metabolism/ (accessed [date]).
A monitoring tool with no regulatory value: check every item at its source.